![](/img/cover-not-exists.png)
516 Different genetic profiles of resistant and sensitive patients with EGFR wild type NSCLC undergoing tyrosine kinase inhibitor (TKI) treatment
Ulivi, P.U., Chiadini, E.C., Dubini, A.D., Calistri, D.C., Puccetti, M.P., Burgio, M.A.B., Delmonte, A.D., Verlicchi, A.V., Gamboni, A.G., Papi, M.P., Zoli, W.Z., Crinò, L.C., Dazzi, C.D.Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(14)70642-2
Date:
November, 2014
File:
PDF, 54 KB
english, 2014